Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Pro-Tumorigenic Responses in Metastatic Niches: An Immunological Perspective Publisher Pubmed



Mirzapour MH1, 2 ; Heidariforoozan M2, 3 ; Razi S2, 4, 5 ; Rezaei N5, 6, 7
Authors
Show Affiliations
Authors Affiliations
  1. 1. School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Cancer Immunology Project (CIP), Universal Scientific Education and Research Network (USERN), Tehran, Iran
  3. 3. Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  4. 4. School of Medicine, Iran University of Medical Sciences, Tehran, Iran
  5. 5. Research Center for Immunodeficiencies, Children’s Medical Center, Tehran University of Medical Sciences, Dr Qarib St, Keshavarz Blvd, Tehran, 14194, Iran
  6. 6. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  7. 7. Cancer Immunology Project (CIP), Universal Scientific Education and Research Network (USERN), Stockholm, Sweden

Source: Clinical and Translational Oncology Published:2023


Abstract

Metastasis is the leading cause of mortality related to cancer. In the course of metastasis, cancer cells detach from the primary tumor, enter the circulation, extravasate at secondary sites, and colonize there. All of these steps are rate limiting and decrease the efficiency of metastasis. Prior to their arrival, tumor cells can modify the secondary sites. These favorable microenvironments increase the probability of successful dissemination and are referred to as pre-metastatic niches. Cancer cells use different mechanisms to induce and maintain these niches, among which immune cells play prominent roles. The immune system, including innate and adaptive, enhances recruitment, extravasation, and colonization of tumor cells at distant sites. In addition to immune cells, stromal cells can also contribute to forming pre-metastatic niches. This review summarizes the pro-metastatic responses conducted by immune cells and the assistance of stromal cells and endothelial cells in the induction of pre-metastatic niches. © 2022, The Author(s), under exclusive licence to Federacion de Sociedades Espanolas de Oncologia (FESEO).
Related Docs
View other Related Docs
1. Tumor Immunology, Clinical Immunology (2022)
2. Pro-Tumorigenic Functions of Macrophages at the Primary, Invasive and Metastatic Tumor Site, Cancer Immunology# Immunotherapy (2020)
3. Cancer Immunology, Encyclopedia of Infection and Immunity (2022)
4. Roles of Myeloid-Derived Suppressor Cells in Cancer Metastasis: Immunosuppression and Beyond, Archivum Immunologiae et Therapiae Experimentalis (2019)
5. Tumor-Associated Macrophages: Role in Cancer Development and Therapeutic Implications, Cellular Oncology (2019)
6. Cancer-Associated Fibroblasts (Cafs) and Tumor-Associated Macrophages (Tams); Where Do They Stand in Tumorigenesis and How They Can Change the Face of Cancer Therapy?, European Journal of Pharmacology (2022)
7. Eosinophils in the Tumor Microenvironment: Implications for Cancer Immunotherapy, Journal of Translational Medicine (2023)
8. Role of Tumor Microenvironment in Cancer Stem Cells Resistance to Radiotherapy, Current Cancer Drug Targets (2022)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (9)
Alimohammad Alizadeh (2)
Other Related Docs
9. Immunology of Cutaneous Tumors and Immunotherapy for Melanoma, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2015)
10. Breast Tumor Metastasis Following Filgrastim Administration Due to the Sdf-1/Cxcr4 Pathway, Medical Oncology (2023)
11. Cancer-Associated Mesenchymal Stem/Stromal Cells: Role in Progression and Potential Targets for Therapeutic Approaches, Frontiers in Immunology (2023)
12. Pathogenesis of Breast Cancer Metastasis to Brain: A Comprehensive Approach to the Signaling Network, Molecular Neurobiology (2016)
13. The Role of the Tumor Microenvironment in Colorectal Cancer and the Potential Therapeutic Approaches, Journal of Clinical Laboratory Analysis (2022)
14. Antimetastatic Effects of Curcumin in Oral and Gastrointestinal Cancers, Frontiers in Pharmacology (2021)
15. An Update to Experimental and Clinical Aspects of Tumor-Associated Macrophages in Cancer Development: Hopes and Pitfalls, Clinical and Experimental Medicine (2024)
16. Comparative Analysis of Protein-Protein Interaction Networks in Metastatic Breast Cancer, PLoS ONE (2022)
17. The Roles of Metabolic Profiles and Intracellular Signaling Pathways of Tumor Microenvironment Cells in Angiogenesis of Solid Tumors, Cell Communication and Signaling (2022)
18. Identification and Validation of Stage-Associated Pbmc Biomarkers in Breast Cancer Using Ms-Based Proteomics, Frontiers in Oncology (2020)
19. The Molecular Signature of Breast Cancer Metastasis to Bone, Anti-Cancer Drugs (2016)
20. The Complex Role of Macrophages in Pancreatic Cancer Tumor Microenvironment: A Review on Cancer Progression and Potential Therapeutic Targets, Discover Oncology (2024)
21. 3D Bioprinting Technology to Mimic the Tumor Microenvironment: Tumor-On-A-Chip Concept, Materials Today Advances (2021)
22. Unraveling the Impact of 27-Hydroxycholesterol in Autoimmune Diseases: Exploring Promising Therapeutic Approaches, Pathology Research and Practice (2023)
23. Anti-Cancer Therapeutic Strategies Based on Hgf/Met, Epcam, and Tumor-Stromal Cross Talk, Cancer Cell International (2022)
24. Association Between Some Helminths and Tumorigenesis Through Immunological and Biochemical Factors, Current Cancer Therapy Reviews (2023)
25. Role of Iron in Cancer Development by Viruses, Reviews in Medical Virology (2019)
26. Contribution of Tumor Microenvironment (Tme) to Tumor Apoptosis, Angiogenesis, Metastasis, and Drug Resistance, Medical Oncology (2025)
27. The Immunobiology of Myeloid-Derived Suppressor Cells in Cancer, Tumor Biology (2016)
28. Cancer Nanomedicine: Special Focus on Cancer Immunotherapy, Cancer Immunology: Bench to Bedside Immunotherapy of Cancers# Second Edition (2020)
29. Immunoregulation by Resveratrol; Implications for Normal Tissue Protection and Tumour Suppression, Clinical and Experimental Pharmacology and Physiology (2023)
30. Melatonin for Gastric Cancer Treatment: Where Do We Stand?, Naunyn-Schmiedeberg's Archives of Pharmacology (2025)
31. The Footprint of Kynurenine Pathway in Every Cancer: A New Target for Chemotherapy, European Journal of Pharmacology (2021)
32. Tumor-Associated Macrophages and Epithelial–Mesenchymal Transition in Cancer: Nanotechnology Comes Into View, Journal of Cellular Physiology (2018)
33. Prognostic Value of Nlr, Plr, Sii, and Dnlr in Urothelial Bladder Cancer Following Radical Cystectomy, Clinical Genitourinary Cancer (2024)
34. Interactions Between Platelets and Leukocytes in Ovarian Cancer: A New Approach to Cancer Treatment: A Review, Indian Journal of Gynecologic Oncology (2025)
35. Cross-Talk Between Non-Ionizing Electromagnetic Fields and Metastasis; Emt and Hybrid E/M May Explain the Anticancer Role of Emfs, Progress in Biophysics and Molecular Biology (2023)
36. P38 Mapk Signaling in Chronic Obstructive Pulmonary Disease Pathogenesis and Inhibitor Therapeutics, Cell Communication and Signaling (2023)
37. Tumor-Suppressing and Anti-Angiogenic Activities of a Recombinant Anti-Cd3ϵ Nanobody in Breast Cancer Mice Model, Immunotherapy (2019)
38. Immune Microenvironment in Different Molecular Subtypes of Ductal Breast Carcinoma, Breast Cancer Research and Treatment (2021)
39. Studying Breast Cancer Lung Metastasis Using a Multi-Compartment Microfluidic Device With a Mimetic Tumor-Stroma Interaction Model, Translational Oncology (2025)
40. Micrornas, Long Non-Coding Rnas, and Circular Rnas and Gynecological Cancers: Focus on Metastasis, Frontiers in Oncology (2023)
41. Lung Cancer-Associated Brain Metastasis: Molecular Mechanisms and Therapeutic Options, Cellular Oncology (2017)
42. Image-Based Multiplex Immune Profiling of Cancer Tissues: Translational Implications. a Report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer, Journal of Pathology (2024)
43. Understanding the Tumor Microenvironment for Effective Immunotherapy, Medicinal Research Reviews (2021)